| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.099 | 0.007 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.095 | 0.007 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.007 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.008 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.4 | 0.009 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.009 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.01 |